Skip to main content
Equibles

Versant Venture Management, LLC

Position in SKYE — Skye Bioscience, Inc.

CIK 1560009 San Francisco, CA
Back to SKYE Full portfolio

Position in SKYE

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$173,992
+$19,751 QoQ
Shares Held
250,963
0.0% QoQ
Ownership
5.67%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#2
of 42 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in SKYE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Versant Venture Management, LLC holds $161,394,736 across 8 Biotechnology names. SKYE ranks #8 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GLUE
Monte Rosa Therapeutics, Inc.
 3,180,780 $76,974,876
2 IPSC
Century Therapeutics, Inc.
 12,166,109 $29,806,967
3 JBIO
Jade Biosciences, Inc.
 991,783 $22,037,418
4 LENZ
LENZ Therapeutics, Inc.
 2,656,888 $15,091,123
5 CTNM
Contineum Therapeutics, Inc.
 542,628 $8,893,672
6 CRSP
CRISPR Therapeutics AG
 148,831 $8,117,242
7 TPST
Tempest Therapeutics, Inc.
 269,772 $299,446
8 SKYE
Skye Bioscience, Inc.
This page 		250,963 $173,992

All Filings in SKYE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $173,992 2,007,704
2026-03-31 $154,241 2,007,704
2025-12-31 $188,146 2,007,704
2025-09-30 $986,284 2,007,704
2025-06-30 $1,049,025 2,007,704
2025-03-31 $399,031 2,007,704
2024-12-31 $710,225 2,007,704
2024-09-30 $981,265 2,007,704
2024-06-30 $2,010,213 2,007,704
2024-03-31 $3,925,057 2,007,702